Related Experiment Video
Updated: Mar 7, 2026

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.4K
[Immunotherapy for head and neck squamous cell carcinoma].
1Department of Otorhinolaryngology Head and Neck Surgery, Eye Ear Nose Throat Hospital of Fndan University, Shanghai 200031, China.
Summary
Head and neck squamous cell carcinoma (HNSCC) is a common cancer with a poor prognosis. Cancer immunotherapy offers a promising new treatment strategy, showing sustained antitumor reactions and overcoming chemoresistance.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Head and neck squamous cell carcinoma (HNSCC) represents a significant global health challenge, ranking as the sixth most common human malignancy.
- Despite advancements in conventional treatments like surgery, chemotherapy, and radiotherapy, the prognosis for advanced HNSCC remains unfavorable.
Purpose of the Study:
- To review the current landscape and advancements in cancer immunotherapy specifically for Head and Neck Squamous Cell Carcinoma (HNSCC).
- To highlight immunotherapy as a burgeoning fourth pillar of cancer treatment.
Main Methods:
- Literature review of existing research on cancer immunotherapy in the context of HNSCC.
- Analysis of the mechanisms, efficacy, and challenges of current immunotherapeutic approaches for HNSCC.
Main Results:
- Cancer immunotherapy demonstrates potential for sustained antitumor responses in HNSCC.
- Immunotherapy offers an alternative that bypasses typical chemoresistance observed with traditional therapies.
Conclusions:
- Immunotherapy is emerging as a critical and effective fourth treatment modality for HNSCC.
- Further research and clinical application of immunotherapy are crucial for improving outcomes in advanced HNSCC.
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

